For citations:
Kosolapov E.G., Kochenkov F.S., Pogudina N.L., Blinov D.V., Bondarenko N.L., Karaulov A.V. COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2017;10(2):22-30. (In Russ.) https://doi.org/10.17749/2070-4909.2017.10.2.022-030
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 